Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Dermatology | Family Medicine | Infections | Internal Medicine | Nursing | Pediatrics | Pharmacy | Institutional

Back to Journal Articles

Varizig Approved to Reduce Chickenpox Symptoms

Last Updated: December 21, 2012.

Varizig (varicella zoster immune globulin) has been approved by the U.S. Food and Drug Administration to minimize chickenpox symptoms when administered within four days of exposure to the virus that causes the disease.

 

To be used within four days of exposure

Share |

Comments: (0)

Tell-a-Friend

 

  Advertisement

FRIDAY, Dec. 21 (HealthDay News) -- Varizig (varicella zoster immune globulin) has been approved by the U.S. Food and Drug Administration to minimize chickenpox symptoms when administered within four days of exposure to the virus that causes the disease.

Varizig was approved for high-risk people, including those with compromised immune systems, newborns, pregnant women, premature infants, children less than a year old, and people with no immunity to the virus, the FDA said Friday in a news release.

Varizig is produced from the blood plasma of healthy donors with high levels of antibodies to the chicken-pox-causing virus, the FDA said. The donated plasma comes from collection facilities licensed by the FDA.

The drug is meant to be administered in one or more doses, depending on the recipient's weight, within 96 hours of exposure. The most common side effects noted in clinical testing were injection-site pain and headache.

Varizig is produced by Cangene Corp., based in Winnipeg, Canada.

More Information

Copyright © 2012 HealthDay. All rights reserved.


Previous: Gattex Approved for Short Bowel Syndrome Next: FDA Expands Tamiflu Use to Treat Babies Under 1 Year Old

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

 
     

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2016
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.